Results 91 to 100 of about 28,129 (278)
Abstract Aim Mebendazole (MBZ), a benzimidazole anthelmintic with established clinical use, has emerged as a repurposing candidate for primary brain tumours due to its multimodal anticancer actions and central nervous system penetrance. This systematic review synthesizes preclinical and clinical evidence evaluating MBZ's efficacy, mechanisms of action ...
Ciara B. Blum +5 more
wiley +1 more source
Radiation sensitizing effect of COX-2 inhibitor, celecoxib, in HCT-116 colorectal cancer cell line
의과학과/석사[한글] 대장암은 서구에서 가장 많은 암종이며 최근 우리 나라에서 크게 증가하고 있는 추세로, 대장암에 대한 화학적 예방에 대한 연구도 활발히 진행되고 있다. 그 중 대표적인 예가 cyclooxygenase (COX)-2와 그의 억제제에 대한 연구이다. COX-2는 여러 암 세포에서 항시적으로 발현되는 것으로 알려져 있으며, 대장암 세포주를 포함한 여러 암세포주에서 COX-2의 선택적 억제제가 발암을 방지하는 효과가 있고, 생체 내외에서
김현석
core
A Pooled Analysis of Thyroid Cancer Incidence Following Radiotherapy for Childhood Cancer
Childhood cancer five-year survival now exceeds 70-80%. Childhood exposure to radiation is a known thyroid carcinogen; however, data are limited for the evaluation of radiation dose-response at high doses, modifiers of the dose-response relationship and ...
de Vathaire, Florent +26 more
core +1 more source
Harnessing ferroptosis from multilayer defense networks to nanoplatforms for specific cancer therapy
Nanomaterials target metabolically‐regulated ferroptosis for cancer therapy. Iron‐based or alternative nanoplatforms integrate ferroptosis with chemotherapy, immunotherapy, or radiotherapy. They enable stimulus‐responsive therapies (photothermal, photodynamic, sonodynamic) activated by near‐infrared, light, or ultrasound, achieving potent synergistic ...
Xinyue Xu +5 more
wiley +1 more source
Tackling cancer stemness with nanotechnology in the era of precision medicine
Precise customization of nanoparticles (NPs) enables active targeting of cancer stem cells (CSCs), thereby improving drug delivery and therapeutic efficacy. NP‐based probing enhances CSC detection through imaging and liquid biopsy, whereas diverse therapeutic payloads improve therapeutic outcomes.
Shaolei Guo +9 more
wiley +1 more source
Selective PARP-1 Targeting for Designing Chemo/Radio Sensitizing Agents
Poly(ADP-ribose) polymerase-1 (PARP-1) is a central signaling enzyme in a cell nucleus. PARP-1 is a target for the development of radio and chemo sensitizing agents in cancer treatment as well as providing protection from stroke. An SH3 domain and an SH3
Oliveira, Marcos
core
Exposure to ionizing radiation or a variety of chemical agents is known to increase the risk of developing malignancy and many tumors have been linked to inflammatory processes.
Lorimore, S.A. +3 more
core +1 more source
A glycosylated dendrimer nanoamplifier hijacks DNA damage‐immune crosstalk for enhanced radio‐immunotherapy of glioblastoma. The responsive release of demethylcantharidin simultaneously blocks repair‐mediated resistance by inhibiting DNA repair and overcomes adaptive immune resistance.
Cong Song +10 more
wiley +1 more source
University of California Radiation Laboratory Reports UCRL-1743
A controversy exists as to the effect of inositol and other lipotropic agents on serum cholesterol levels and atherosclerosis in humans and animals. There is no general agreement that these agents lower serum cholesterol levels or exert an inhibitory ...
Kritchevsky, David, 1920-2006 +1 more
core
We report on the photophysical properties and electronic relaxation mechanisms of 4‐dimethylaminophthalimide (DMAP) and thio‐4‐dimethylaminophthalimide (SDMAP). While DMAP is fluorescent, SDMAP shows negligible fluorescence due to ultrafast intersystem crossing to a long‐lived triplet state that decays in 3.4 ± 0.05 µs.
Chris Acquah +8 more
wiley +1 more source

